Dr Kathleen Ann Boss, PSYD | |
220 Jack Martin Blvd # E2, Brick, NJ 08724-7772 | |
(732) 920-3434 | |
Not Available |
Full Name | Dr Kathleen Ann Boss |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 220 Jack Martin Blvd # E2, Brick, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992142673 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 35SI00599100 (New Jersey) | Primary |
Entity Name | Shore Psychological Healthcare Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477563534 PECOS PAC ID: 6305846379 Enrollment ID: O20061226000015 |
News Archive
The growing burden of alcohol-related liver disease (ARLD) could be reduced if hospitals introduced a simple universal screening procedure for those attending acute and emergency hospital settings, according to a new study shared today at The International Liver Congress in Barcelona, Spain.
A large nationwide longitudinal study found no evidence of an increased risk of cancer in children born near nuclear power plants in Switzerland.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.
Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, announces today the completion of two Phase I clinical trials with its unacylated ghrelin analog AZP-531 in 76 healthy volunteers and overweight or obese subjects.
› Verified 2 days ago
Entity Name | Phc Of Buffalo Grove Clinical Psychology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235430612 PECOS PAC ID: 7416194683 Enrollment ID: O20140827000785 |
News Archive
The growing burden of alcohol-related liver disease (ARLD) could be reduced if hospitals introduced a simple universal screening procedure for those attending acute and emergency hospital settings, according to a new study shared today at The International Liver Congress in Barcelona, Spain.
A large nationwide longitudinal study found no evidence of an increased risk of cancer in children born near nuclear power plants in Switzerland.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.
Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, announces today the completion of two Phase I clinical trials with its unacylated ghrelin analog AZP-531 in 76 healthy volunteers and overweight or obese subjects.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kathleen Ann Boss, PSYD 220 Jack Martin Blvd # E2, Brick, NJ 08724-7772 Ph: (732) 920-3434 | Dr Kathleen Ann Boss, PSYD 220 Jack Martin Blvd # E2, Brick, NJ 08724-7772 Ph: (732) 920-3434 |
News Archive
The growing burden of alcohol-related liver disease (ARLD) could be reduced if hospitals introduced a simple universal screening procedure for those attending acute and emergency hospital settings, according to a new study shared today at The International Liver Congress in Barcelona, Spain.
A large nationwide longitudinal study found no evidence of an increased risk of cancer in children born near nuclear power plants in Switzerland.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.
Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, announces today the completion of two Phase I clinical trials with its unacylated ghrelin analog AZP-531 in 76 healthy volunteers and overweight or obese subjects.
› Verified 2 days ago
Dr. George William Mcdermott, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 115 Princeton Ave, Brick, NJ 08724 Phone: 732-458-6748 | |
Alyssa Marie Cocchiarella, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 711 Marys Dr, Brick, NJ 08723 Phone: 732-288-5696 | |
Dr. Justine Fulton, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 445 Brick Blvd Ste 302, Brick, NJ 08723 Phone: 908-415-6354 | |
Carole M Beyer, ED D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1683 Route 88, Brick, NJ 08724 Phone: 732-840-5266 Fax: 732-840-7840 | |
Dr. Adam David Christmann, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1683 Route 88 W Ste A, Brick, NJ 08724 Phone: 732-840-5266 | |
Dr. Jay B Gordon, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1683 Route 88, Brick, NJ 08724 Phone: 732-840-5266 Fax: 732-840-7840 | |
Nicholas Nestor Perez, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1683 Nj-88, Brick, NJ 08724 Phone: 732-840-5266 |